Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new diovan clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on diovan
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
Status: Completed, Condition Summary: Hypertension - Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Status: Recruiting, Condition Summary: Hypertension - Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>75) With Mild-Moderate Hypertension.
Status: Recruiting, Condition Summary: Hypertension - Open Label Extension Study to Evaluate the Long Term Use of Valsartan in 1-5 Year Old Hypertensive Children
Status: Recruiting, Condition Summary: Hypertension - Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
Status: Recruiting, Condition Summary: Hypertension - Long Term Safety, Tolerability and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension
Status: Recruiting, Condition Summary: Hypertension - A Study to Evaluate the Efficacy and Safety of TAK-491 Compared to Valsartan and Olmesartan in Subjects With Essential Hypertension
Status: Recruiting, Condition Summary: Essential Hypertension - Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Status: Completed, Condition Summary: Hypertension - Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Status: Completed, Condition Summary: Hypertension - Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
Status: Recruiting, Condition Summary: Type 2 Diabetes Mellitus; Nephropathy - GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
Status: Completed, Condition Summary: Atrial Fibrillation - Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
Status: Completed, Condition Summary: Hypertension - A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Status: Recruiting, Condition Summary: Glomerulonephritis, IGA - Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
Status: Not yet recruiting, Condition Summary: Hypertension - A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 mg + Hydrochlorothiazide 25 mg [Micardis HCT] Versus Valsartan 160 mg + Hydrochlorothiazide 25 mg [Diovan HCT] Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension.
Status: Completed, Condition Summary: Hypertension - A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient
Status: Completed, Condition Summary: Hypertension - Telmisartan vs. Valsartan Missed Dose
Status: Completed, Condition Summary: Hypertension - A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
Status: Completed, Condition Summary: Chronic Heart Failure - Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
Status: Completed, Condition Summary: Hypertension - A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
Status: Active, not recruiting, Condition Summary: Hypertension - Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes
Status: Recruiting, Condition Summary: Hypertension; Diabetes; Coronary Artery Disease - Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
Status: Recruiting, Condition Summary: Hypertension - Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
Status: Recruiting, Condition Summary: Post Acute Coronary Syndrome; Myocardial Ischemia - Effectiveness of Losartan 50 mg/HCTZ 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Hypertension Not Controlled on Monotherapy
Status: Active, not recruiting, Condition Summary: Hypertension - Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
Status: Completed, Condition Summary: Hypertension - VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
Status: Completed, Condition Summary: Hypertension - 8-Week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
Status: Completed, Condition Summary: Hypertension - Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
Status: Active, not recruiting, Condition Summary: Hypertension; Hypertrophy, Left Ventricular - A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
Status: Active, not recruiting, Condition Summary: Hypertension; Diabetic Nephropathy - A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
Status: Active, not recruiting, Condition Summary: Hypertension; Hypercholesterolemia